Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

REPS2

Introduction

RalBP1-associated Eps domain-containing protein 2 is a protein that in humans is encoded by the REPS2 gene.[1][2][3]

Function

Function

The product of this gene is part of a protein complex that regulates the endocytosis of growth factor receptors. The encoded protein directly interacts with a GTPase activating protein that functions downstream of the small G protein Ral. Its expression can negatively affect receptor internalization and inhibit growth factor signaling. Multiple transcript variants encoding different isoforms have been found for this gene.[3]

Interactions

Interactions

REPS2 has been shown to interact with EPN1,[4] EPS15[5] and RALBP1.[1]

References

References

  1. ↑ 1.0 1.1 Ikeda M, Ishida O, Hinoi T, Kishida S, Kikuchi A (Feb 1998). “Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral”. J Biol Chem. 273 (2): 814–21. doi:10.1074/jbc.273.2.814. PMID 9422736.
  2. ↑ Koshiba S, Kigawa T, Iwahara J, Kikuchi A, Yokoyama S (Feb 1999). “Solution structure of the Eps15 homology domain of a human POB1 (partner of RalBP1)”. FEBS Lett. 442 (2–3): 138–42. doi:10.1016/S0014-5793(98)01644-5. PMID 9928989.
  3. ↑ 3.0 3.1 “Entrez Gene: REPS2 RALBP1 associated Eps domain containing 2”.
  4. ↑ Morinaka K, Koyama S, Nakashima S, Hinoi T, Okawa K, Iwamatsu A, Kikuchi A (Oct 1999). “Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis”. Oncogene. 18 (43): 5915–22. doi:10.1038/sj.onc.1202974. PMID 10557078.
  5. ↑ Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, Iwamatsu A, Kishida S, Kikuchi A (Jul 1999). “Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors”. EMBO J. 18 (13): 3629–42. doi:10.1093/emboj/18.13.3629. PMC 1171441. PMID 10393179.
Further reading

Further reading

  • Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, Iwamatsu A, Kishida S, Kikuchi A (1999). “Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors”. EMBO J. 18 (13): 3629–42. doi:10.1093/emboj/18.13.3629. PMC 1171441. PMID 10393179.
  • Morinaka K, Koyama S, Nakashima S, Hinoi T, Okawa K, Iwamatsu A, Kikuchi A (1999). “Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis”. Oncogene. 18 (43): 5915–22. doi:10.1038/sj.onc.1202974. PMID 10557078.
  • Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H (2002). “Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway”. J. Biol. Chem. 277 (21): 19008–18. doi:10.1074/jbc.M112472200. PMID 11882656.
  • Oshiro T, Koyama S, Sugiyama S, Kondo A, Onodera Y, Asahara T, Sabe H, Kikuchi A (2002). “Interaction of POB1, a downstream molecule of small G protein Ral, with PAG2, a paxillin-binding protein, is involved in cell migration”. J. Biol. Chem. 277 (41): 38618–26. doi:10.1074/jbc.M203453200. PMID 12149250.
  • Oosterhoff JK, Penninkhof F, Brinkmann AO, Anton Grootegoed J, Blok LJ (2003). “REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells”. Oncogene. 22 (19): 2920–5. doi:10.1038/sj.onc.1206397. PMID 12771942.
  • Rossé C, L’Hoste S, Offner N, Picard A, Camonis J (2003). “RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis”. J. Biol. Chem. 278 (33): 30597–604. doi:10.1074/jbc.M302191200. PMID 12775724.
  • Penninkhof F, Grootegoed JA, Blok LJ (2004). “Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells”. Oncogene. 23 (33): 5607–15. doi:10.1038/sj.onc.1207750. PMID 15184881.
  • Oosterhoff JK, Kühne LC, Grootegoed JA, Blok LJ (2005). “EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2”. Int. J. Cancer. 113 (4): 561–7. doi:10.1002/ijc.20612. PMID 15455380.
  • Yadav S, Zajac E, Singhal SS, Singhal J, Drake K, Awasthi YC, Awasthi S (2005). “POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis”. Biochem. Biophys. Res. Commun. 328 (4): 1003–9. doi:10.1016/j.bbrc.2005.01.055. PMID 15707977.